404 related articles for article (PubMed ID: 28931043)
1. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
[TBL] [Abstract][Full Text] [Related]
2. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
6. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
7. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
[TBL] [Abstract][Full Text] [Related]
8. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
Jeong IG; Han KS; Joung JY; Seo HK; Chung J
BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
[TBL] [Abstract][Full Text] [Related]
9. Renal function is associated with prognosis in stent-change therapy for malignant ureteral obstruction.
Yoon JH; Park S; Park S; Moon KH; Cheon SH; Kwon T
Investig Clin Urol; 2018 Nov; 59(6):376-382. PubMed ID: 30402570
[TBL] [Abstract][Full Text] [Related]
10. Direct primary or secondary percutaneous ureteral stenting: what is the most compliant option in patients with malignant ureteral obstructions?
Carrafiello G; Laganà D; Lumia D; Giorgianni A; Mangini M; Santoro D; Cuffari S; Marconi A; Novario R; Fugazzola C
Cardiovasc Intervent Radiol; 2007; 30(5):974-80. PubMed ID: 17468910
[TBL] [Abstract][Full Text] [Related]
11. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
[TBL] [Abstract][Full Text] [Related]
12. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
[TBL] [Abstract][Full Text] [Related]
13. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
14. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
Matsuura H; Arase S; Hori Y; Tochigi H
Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
[TBL] [Abstract][Full Text] [Related]
15. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction.
Nas OF; Oztepe MF; Kandemirli SG; Bilgin C; Ozkaya G; Inecikli MF; Kaygısız O
Abdom Radiol (NY); 2021 May; 46(5):2188-2194. PubMed ID: 33226456
[TBL] [Abstract][Full Text] [Related]
16. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors.
Kamiyama Y; Matsuura S; Kato M; Abe Y; Takyu S; Yoshikawa K; Arai Y
Int J Urol; 2011 May; 18(5):379-82. PubMed ID: 21518020
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer.
Heo JE; Jeon DY; Lee J; Han HH; Jang WS
Yonsei Med J; 2023 Nov; 64(11):665-669. PubMed ID: 37880847
[TBL] [Abstract][Full Text] [Related]
18. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
19. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients.
Patel U; Abubacker MZ
Radiology; 2004 Feb; 230(2):435-42. PubMed ID: 14688404
[TBL] [Abstract][Full Text] [Related]
20. Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction?
Uthappa MC; Cowan NC
Clin Radiol; 2005 May; 60(5):608-12. PubMed ID: 15851050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]